China Jo-Jo Drugstores, Inc.
CJJDNASDAQHealthcare
$1.52
$-0.09(-5.59%)
Market Cap$9947169
P/E Ratio—
52W High$4.5
52W Low$0.8531
China Jo-Jo Drugstores, Inc. (CJJD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CJJD · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2024Report Date: Mar 31, 2024EPS Actual
-$1.96
Revenue
$0.08B
Fiscal Period
Q1 FY2024
FY ends December
Report Date
Mar 31, 2024
After Market Close
CJJD reports quarterly as a NASDAQ-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | May 24, 2026 | — | — | — | — | — | — |
| ◌ Q2 FY2026 | May 24, 2026 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Oct 29, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Jul 4, 2024 | — | — | — | — | — | — |
| — Q1 FY2024 | Mar 31, 2024 | — | -$1.96 | — | $0.08B | — | — |
| — Q3 FY2023 | Sep 30, 2023 | — | -$0.77 | — | $0.08B | — | — |
| ◌ Q3 FY2023 | Sep 28, 2023 | — | — | — | — | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | -$25.91 | — | $0.08B | — | — |
Q2 FY2026
May 24, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 24, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Oct 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Jul 4, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 31, 2024
EPS Actual
-$1.96
EPS Est.
—
EPS Surpr.
—
Revenue
$0.08B
Q3 FY2023
Sep 30, 2023
EPS Actual
-$0.77
EPS Est.
—
EPS Surpr.
—
Revenue
$0.08B
Q3 FY2023
Sep 28, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Mar 31, 2023
EPS Actual
-$25.91
EPS Est.
—
EPS Surpr.
—
Revenue
$0.08B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q2 FY2014 | $0.00 | $0.00 | $0.00 | 4 |
| Q2 FY2010 | $0.10 | $0.13 | $0.16 | 10 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2024 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2024 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2014 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2010 | $0.0B | $0.0B | $0.0B | 10 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2024 | Mar 31, 2024 | — | $3.22 | $3.22 | +0.00% |
| — Q3 FY2023 | Sep 30, 2023 | — | $4.66 | $4.60 | -1.29% |
| — Q1 FY2023 | Mar 31, 2023 | — | $88.20 | $89.60 | +1.59% |
| — Q3 FY2022 | Sep 30, 2022 | — | $39.00 | $39.20 | +0.51% |
| — Q2 FY2022 | Apr 1, 2022 | — | $76.13 | $74.76 | -1.80% |
| — Q1 FY2022 | Mar 31, 2022 | — | $81.60 | $76.13 | -6.70% |
Q1 FY2024+0.00%
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$3.22
Price After
$3.22
Q3 FY2023-1.29%
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
$4.66
Price After
$4.60
Q1 FY2023+1.59%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$88.20
Price After
$89.60
Q3 FY2022+0.51%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$39.00
Price After
$39.20
Q2 FY2022-1.80%
Report Date
Apr 1, 2022
EPS Beat/Miss
—
Price Before
$76.13
Price After
$74.76
Q1 FY2022-6.70%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$81.60
Price After
$76.13
Beat Rate0 / 6 quarters
Largest Move-6.70% (Q1 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CJJD ends December
China Jo-Jo Drugstores, Inc. (CJJD) most recently reported earnings on March 31, 2024 for Q1 FY2024, posting EPS of $-1.96 (in line with the analyst consensus of —). The next CJJD earnings date is expected around September 1, 2026.
Each quarter, investors track CJJD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CJJD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CJJD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CJJD earnings · 4 questionsChina Jo-Jo Drugstores, Inc.'s next earnings report is expected around September 1, 2026. CJJD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CJJD historically reports after market close (AMC).
CJJD earnings datewhen is CJJD earningsCJJD next earnings datewhen does CJJD report earningsCJJD earnings calendar
▸ Source: FMP · China Jo-Jo Drugstores, Inc. SEC filings · US GAAP · China Jo-Jo Drugstores, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026